Systimmune
A Senior Project Manager at SystImmune leads cross-functional planning and execution for oncology biologics programs from discovery through IND submission. The role drives integrated development strategies, manages complex timelines and risks, and ensures alignment across research, regulatory, and clinical teams to advance innovative cancer treatments.
Headquarters
Redmond, Washington, United States
Company Size
11-50 employees
Founded
2014
SystImmune is a Redmond, WA–based biopharmaceutical company developing bi‑specific and multi‑specific antibodies and antibody‑drug conjugates (ADCs) to treat cancer. Its mission is to create biologics that both directly attack tumors and activate the immune system to enhance anti‑tumor responses, using proprietary protein‑engineering and antibody‑discovery platforms. A multidisciplinary team across the U.S. and China focuses on rapid, cost‑efficient clinical development. SystImmune is a member of the Biokin Pharmaceutical group and partners with Bristol Myers Squibb and OrbiMed, and it is seeking additional collaborators to develop and commercialize its therapies worldwide.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Systimmune.
5% below the average for this role
Senior Principal Scientist, Cancer Immunology, Discovery Biology, Oncology Thematic Research Center
Bristol Myers Squibb
Global Therapeutic Research Lead, Oncology – Biologics
Takeda Pharmaceutical Company Limited
Senior Director, Oncology Small Molecule
MSD
Senior Project Manager
ampersandpeople
Discovery Oncology Leader
Merck & Co., Inc.
Principal Scientist, ADCs Discovery Biology, Oncology Thematic Research Center
Bristol Myers Squibb